Singapore markets open in 6 hours 9 minutes

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.1800.000 (0.00%)
At close: 02:53PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,151,145
1,151,145
1,277,682
1,165,155
1,024,270
Cost of revenue
509,626
509,626
504,131
483,893
473,625
Gross profit
641,519
641,519
773,551
681,262
550,645
Operating expenses
Research development
90,808
90,808
79,478
67,028
57,944
Selling general and administrative
260,255
260,255
264,791
226,439
163,796
Total operating expenses
210,136
210,136
329,269
284,321
214,811
Operating income or loss
431,383
431,383
444,282
396,941
335,834
Interest expense
989
989
371
641
4,828
Income before tax
414,057
414,057
438,408
439,323
331,298
Income tax expense
91,390
91,390
82,557
85,160
66,505
Income from continuing operations
322,667
322,667
355,851
354,163
264,793
Net income
326,000
326,000
358,057
358,175
268,130
Net income available to common shareholders
326,000
326,000
358,057
358,175
268,130
Basic EPS
0.30
0.22
0.24
0.24
0.17
Diluted EPS
0.29
0.22
0.24
0.24
0.17
Basic average shares
1,498,931
1,499,620
1,498,551
1,497,543
1,544,589
Diluted average shares
1,503,084
1,502,602
1,502,310
1,507,880
1,545,535